TTNP: Titan Pharmaceuticals, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1997	8.25	5.625	-2.625	-31.82%
1998	5.625	3.8125	-1.8125	-32.22%
1999	3.8125	19.00	15.1875	398.36%
2000	19.00	35.375	16.375	86.18%
2001	35.375	9.81	-25.625	-72.27%
2002	9.81	1.43	-8.38	-85.42%
2003	1.43	2.92	1.49	104.20%
2004	2.92	3.22	0.30	10.27%
2005	3.22	1.43	-1.79	-55.59%
2006	1.43	3.32	1.89	132.17%
2007	3.32	1.68	-1.64	-49.40%
2008	1.68	0.02	-1.66	-98.81%
2009	0.02	2.31	2.29	11450.00%
2010	2.31	1.19	-1.12	-48.48%
2011	1.19	1.14	-0.05	-4.20%
2012	1.14	1.10	-0.04	-3.51%
2013	1.10	0.605	-0.495	-45.00%
2014	0.605	0.462	-0.143	-23.64%
2015	0.462	0.80727	0.34527	74.73%
2016	4.44	4.00	-0.44	-9.91%
2017	4.00	1.325	-2.675	-66.88%
2018	1.325	0.223	-1.102	-83.17%
2019	0.223	0.03235*	-0.19065	-85.49%
2020	0.1941	0.1097*	-0.0844	-43.48%
2021	3.29	1.02	-2.27	-69.00%
2022	1.02	0.7831	-0.2369	-23.23%
2023	0.7831	0.4125	-0.3706	-47.32%
2024	0.4125	0.163	-0.2495	-60.48%

*The 2015 ending price for Titan Pharmaceuticals has been adj. for a 1 for 5.5 reverse stock split.
*The 2019 ending price for Titan Pharmaceuticals has been adj. for a 1 for 6 reverse stock split.
*The 2020 ending price for Titan Pharmaceuticals has been adj. for a 1 for 30 reverse stock split.
*The 2024 ending price for Titan Pharmaceuticals has been adj. for a 1 for 20 reverse stock split.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).